BIOREGENX, INC. Quarterly Cost of Revenue in USD from Q1 2023 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate cost of goods produced and sold and services rendered during the reporting period.
Summary
Bioregenx, Inc. quarterly/annual Cost of Revenue history and growth rate from Q1 2023 to Q3 2024.
  • Bioregenx, Inc. Cost of Revenue for the quarter ending September 30, 2024 was $114K, a 48.8% decline year-over-year.
  • Bioregenx, Inc. annual Cost of Revenue for 2022 was $0.000, a 100% decline from 2021.
Cost of Revenue, Quarterly (USD)
Cost of Revenue, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $114K -$109K -48.8% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-14
Q2 2024 $264K -$813 -0.31% Apr 1, 2024 Jun 30, 2024 10-Q 2024-10-09
Q1 2024 $165K -$146K -46.9% Jan 1, 2024 Mar 31, 2024 10-Q/A 2024-10-09
Q3 2023 $223K Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-14
Q2 2023 $265K Apr 1, 2023 Jun 30, 2023 10-Q 2024-10-09
Q1 2023 $312K Jan 1, 2023 Mar 31, 2023 10-Q/A 2024-10-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.